When responding to an ad for a job caring for patient-detainees along the US southern border, applicants should anticipate the need to navigate dual loyalties.

Streamlining US health care business has raised unique privacy concerns. Bills and explanations of benefits contain protected health information that could be disclosed to someone other than the patient.

Financial relationships are common, and ethical questions rightly emerge about how conflicts of interest compromise investigators’ approaches to research.

Lack of training and lack of knowledge can adversely influence a patient’s clinical outcomes.

Editorial fellow Dr Ariel Wampler describes what few know about material and device regulation, and Dr Adriane Fugh-Berman explains why we should ask more questions about device representatives’ intraoperative roles during implantations.

Jeffrey Bedard joins Ethics Talk to discuss his article: "What Should Patients Be Told About Device Representatives’ Roles at the Point of Surgical Care?"

Ethical dimensions of risk management are illuminated in AMA Code content on discharge planning.

Pharma has long marketed opioids in ways that contribute to opioid use disorder and deaths by overdose. Regulatory mistakes in approving and labeling new analgesics by the FDA didn’t make us safer.

How should physicians researching life-sustaining technologies consider their duties to enrolled subjects?

African cancer research is embedded in underresourced health care infrastructures, illuminating ethical questions about benefit sharing and governance.